Physician profile
David Lu
NPI 1689760522
$4,792.08
in general payments reported to CMS, 2019-2025
12 companies · $51.93 in 2025
The $51.93 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,753 · 2020: $2,637 · 2021: $93.44 · 2022: $109 · 2023: $62.70 · 2024: $85.19 · 2025: $51.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,000.13 | 2019-2020 | |
| Medicure Pharma INC. | $200.00 | 2020 | |
| Abbott Laboratories | $177.91 | 2019-2022 | |
| Boston Scientific Corporation | $102.23 | 2019-2021 | |
| Medtronic, INC. | $94.17 | 2021-2023 | Na |
| Astrazeneca Pharmaceuticals Lp | $85.19 | 2024 | Breztri |
| Shockwave Medical, INC | $35.11 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $30.63 | 2022 | |
| Novo Nordisk INC | $21.76 | 2025 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $15.68 | 2025 | Camzyos |
| Biotronik INC. | $14.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.